You are here

A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
New Haven, Connecticut, 06511 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male subjects and female of non-childbearing potential subjects between the ages of 18
and 55.

- BMI between 18.5 to 32 kg/m2.

- Total body weight ≥40 kg and ≤120 kg.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Previous treatment with an antibody within 6 months prior to Day 1.

- Pregnant or nursing females; females of childbearing potential.

- History of sensitivity to heparin or heparin-induced thrombocytopenia.

NCT01740609
Pfizer
Completed
A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now